Clinical Inertia and 2-Year Glycaemic Trajectories in Patients with Non-Newly Diagnosed Type 2 Diabetes Mellitus in Primary Care: A Retrospective Cohort Study

References

• Luo M, Tan KHX, Tan CS, Lim WY, Tai ES, Venkataraman K. Longitudinal trends in HbA1c patterns and association with outcomes: a systematic review. Diabetes Metab Res Rev. 2018;34(6):e3015. doi:10.1002/dmrr.3015
   PubMed Web of Science ®Google Scholar
• Lacy ME, Gilsanz P, Karter AJ, Quesenberry CP, Pletcher MJ, Whitmer RA. Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes. Diabetes Care. 2018;41(11):2339–2345. doi:10.2337/dc18-0073
   PubMed Web of Science ®Google Scholar
• Laiteerapong N, Karter AJ, Moffet HH, et al. Ten-year hemoglobin A1c trajectories and outcomes in type 2 diabetes mellitus: the Diabetes & Aging Study. J Diabetes Complications. 2017;31(1):94–100. doi:10.1016/j.jdiacomp.2016.07.023
   PubMed Web of Science ®Google Scholar
• Rathmann W, Schwandt A, Hermann JM, et al. DPV Initiative. Distinct trajectories of HbA(1c) in newly diagnosed Type 2 diabetes from the DPV registry using a longitudinal group-based modelling approach. Diabet Med. 2019;36(11):1468–1477. doi:10.1111/dme.14103
   Web of Science ®Google Scholar
• Luo M, Tan CS, Lim WY, et al. Association of diabetes treatment with long-term glycemic patterns in patients with type 2 diabetes mellitus: a prospective cohort study. Diabetes Metab Res Rev. 2019;35(4):e3122. doi:10.1002/dmrr.3122
   Web of Science ®Google Scholar
• Karpati T, Leventer-Roberts M, Feldman B, Cohen-Stavi C, Raz I, Balicer R. Patient clusters based on HbA1c trajectories: a step toward individualized medicine in type 2 diabetes. PLoS One. 2018;13(11):e0207096. doi:10.1371/journal.pone.0207096
   PubMed Web of Science ®Google Scholar
• McCoy RG, Ngufor C, Van Houten HK, Caffo B, Shah ND. Trajectories of Glycemic Change in a National Cohort of Adults With Previously Controlled Type 2 Diabetes. Med Care. 2017;55(11):956–964. doi:10.1097/MLR.0000000000000807
   Web of Science ®Google Scholar
• Rozing MP, Møller A, Aabenhus R, Siersma V, Rasmussen K, Køster-Rasmussen R. Changes in HbA1c during the first six years after the diagnosis of Type 2 diabetes mellitus predict long-term microvascular outcomes. PLoS One. 2019;14(11):e0225230. doi:10.1371/journal.pone.0225230
   Web of Science ®Google Scholar
• Khunti K, Gomes MB, Pocock S, et al. Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: a systematic review. Diabetes Obes Metab. 2018;20(2):427–437. doi:10.1111/dom.13088
   PubMed Web of Science ®Google Scholar
• Andreozzi F, Candido R, Corrao S, et al. Clinical inertia is the enemy of therapeutic success in the management of diabetes and its complications: a narrative literature review. Diabetol Metab Syndr. 2020;7(12):52. doi:10.1186/s13098-020-00559-7
   Web of Science ®Google Scholar
• Chen YY, Peng MG. The validity and reliability of a Chinese version of the diabetes self-care activities questionnaire. Chine J Practical Nursing. 2011;27(14):60–62.
   Google Scholar
• American Diabetes Association; European Association for the Study of Diabetes; International Federation of Clinical Chemistry and Laboratory Medicine; International Diabetes Federation. Consensus statement on the worldwide standardisation of the HbA1c measurement. Diabetologia. 2007;50:2042–2043. doi:10.1007/s00125-007-0789-7
   Web of Science ®Google Scholar
• Looker HC, Nyangoma SO, Cromie D, et al. Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia. 2012;55(9):2335–2342. doi:10.1007/s00125-012-2596-z. Epub 2012 Jun 12. PMID: 22688348; PMCID: PMC3411303.
   Web of Science ®Google Scholar
• McGrath K, Edi R. Diabetic Kidney Disease: diagnosis, Treatment, and Prevention. Am Fam Physician. 2019;99(12):751–759. PMID: 31194487.
   Web of Science ®Google Scholar
• Selvarajah D, Kar D, Khunti K, et al. Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. Lancet Diabetes Endocrinol. 2019;7(12):938–948. doi:10.1016/S2213-8587(19)30081-6. Epub 2019 Oct 14. PMID: 31624024.
   PubMed Web of Science ®Google Scholar
• Pathiraja NP, Colman PG, Wentworth JM. Glycaemic trajectory and predictors of suboptimal glycaemic control in people with type 2 diabetes. Intern Med J. 2020;50(11):1415–1418. doi:10.1111/imj.15059. PMID: 33215839.
   Web of Science ®Google Scholar
• Cicero AFG, Fogacci F, Tocci G, et al. Awareness of major cardiovascular risk factors and its relationship with markers of vascular aging: data from the Brisighella Heart Study. Nutr Metab Cardiovasc Dis. 2020;30(6):907–914. doi:10.1016/j.numecd.2020.03.005. Epub 2020 Mar 16. PMID: 32249143.
   PubMed Web of Science ®Google Scholar
• Ji H, Chen R, Huang Y, Li WQ, Shi CH, Zhou J. Effect of simulation education and case management on glycemic control in type 2 diabetes. Diabetes Metab Res Rev. 2019;35(3):e3112. doi:10.1002/dmrr.3112
   Web of Science ®Google Scholar
• Weinstock RS, Braffett BH, McGuigan P, et al.; TODAY Study Group. Self-Monitoring of Blood Glucose in Youth-Onset Type 2 Diabetes: results From the TODAY Study. Diabetes Care. 2019;42(5):903–909. doi:10.2337/dc18-1854.
   Web of Science ®Google Scholar
• Balducci S, D’Errico V, Haxhi J, et al. Italian Diabetes and Exercise Study 2 (IDES-_2) Investigators. Effect of a Behavioral Intervention Strategy for Adoption and Maintenance of a Physically Active Lifestyle: the Italian Diabetes and Exercise Study 2 (IDES_2): a Randomized Controlled Trial. Diabetes Care. 2017;40(11):1444–1452. doi:10.2337/dc17-0594
   PubMed Web of Science ®Google Scholar
• Fayehun AF, Olowookere OO, Ogunbode AM, Adetunji AA, Esan A. Walking prescription of 10 000 steps per day in patients with type 2 diabetes mellitus: a randomised trial in Nigerian general practice [J]. Br J Gen Pract. 2018;68(667):e139–e145. doi:10.3399/bjgp18X694613
   Web of Science ®Google Scholar
• Chinese Diabetes Society. Chinese guideline for clinical application of blood glucose monitoring (2015 Edition). Chin J Diabetes Mellitus. 2015;7(10):603–613.
   Google Scholar
• Madeo B, Diazzi C, Granata ARM, et al. Effect of a standard schema of self-monitoring blood glucose in patients with poorly controlled, non-insulin-treated type 2 diabetes mellitus: a controlled longitudinal study. J Popul Ther Clin Pharmacol. 2020;27(S Pt 2):e1–e11. doi:10.15586/jptcp.v27iSP2.680. PMID: 32757545.
   Web of Science ®Google Scholar
• Salinero-Fort MA, Carrillo-de E, Arrieta-Blanco FJ, et al. Effectiveness of PRECEDE model for health education on changes and level of control of HbA1c, blood pressure, lipids, and body mass index in patients with type 2 diabetes mellitus. BMC Public Health. 2011;11:267. doi:10.1186/1471-2458-11-267
   PubMed Web of Science ®Google Scholar
• Drake TC, Hsu FC, Hire D, et al. Factors associated with failure to achieve a glycated haemoglobin target of <8.0% in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Obes Metab. 2016;18(1):92–95.
   Web of Science ®Google Scholar
• Turchin A, Goldberg SI, Breydo E, Shubina M, Einbinder JS. Copy/paste documentation of lifestyle counseling and glycemic control in patients with diabetes: true to form? Arch Intern Med. 2011;171:1393–1394. doi:10.1001/archinternmed.2011.219
   PubMedGoogle Scholar
• Lind M, Pivodic A, Cea-Soriano L, Nerman O, Pehrsson NG, Garcia-Rodriguez LA. Changes in HbA1c and frequency of measuring HbA1c and adjusting glucose-lowering medications in the 10 years following diagnosis of type 2 diabetes: a population-based study in the UK. Diabetologia. 2014;57(8):1586–1594. doi:10.1007/s00125-014-3250-8
   Web of Science ®Google Scholar
• Kostev K, Jacob L, Lucas A, Rathmann W. Low annual frequency of HbA(1c) testing in people with Type 2 diabetes in primary care practices in Germany. Diabet Med. 2018;35(2):249–254. doi:10.1111/dme.13556
   Web of Science ®Google Scholar
• McCoy RG, Van Houten HK, Ross JS, Caffo B, Shah ND. HbA1c overtesting and overtreatment among US adults with controlled type 2 diabetes, 2001-13: observational population based study. BMJ. 2015;351:h6138. doi:10.1136/bmj.h6138
   PubMed Web of Science ®Google Scholar
• Duff CJ, Solis-Trapala I, Driskell OJ, et al. The frequency of testing for glycated haemoglobin, HbA1c, is linked to the probability of achieving target levels in patients with suboptimally controlled diabetes mellitus. Clin Chem Lab Med. 2018;57(2):296–304. doi:10.1515/cclm-2018-0503
   Web of Science ®Google Scholar
• Driskell OJ, Holland D, Waldron JL, et al. Reduced testing frequency for glycated hemoglobin, HbA1c, is associated with deteriorating diabetes control. Diabetes Care. 2014;37(10):2731–2737. doi:10.2337/dc14-0297
   PubMed Web of Science ®Google Scholar